Literature DB >> 17877427

Characterization of the theorectical radiation dose enhancement from nanoparticles.

John C Roeske1, Luis Nunez, Mark Hoggarth, Edwardine Labay, Ralph R Weichselbaum.   

Abstract

Recently, nanoparticles have been considered as a method of providing radiation dose enhancement in tumors. In order to quantify this affect, a dose enhancement factor (DEF) is defined that represents the ratio of the dose deposited in tumor with nanoparticles, divided by the dose deposited in the tumor without nanoparticles. Materials with atomic numbers (Z) ranging from 25 to 90 are considered in this analysis. In addition, the energy spectrum for a number of external beam x-ray sources and common radionuclides are evaluated. For a nanoparticle concentration of 5 mg/ml, the DEF is < 1.05 for Co-60, Ir-192, Au-198, Cs-137, 6, 18, and 25 MV x-rays for all materials considered. However, relatively large increases in the DEF are observed for 50, 80, 100, and 140 KVp x-rays as well as Pd-103 and I-125. The DEF increases for all sources as Z varies from 25-35. From Z = 40-60, the DEF plateaus or slightly decreases. For higher Z materials (Z>70), the DEF increases and is a maximum for the highest Z materials. High atomic number nanoparticles coupled with low energy external beam x-rays or brachytherapy sources offer the potential of significantly enhancing the delivered dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877427     DOI: 10.1177/153303460700600504

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  39 in total

Review 1.  Gold nanoparticles as novel agents for cancer therapy.

Authors:  S Jain; D G Hirst; J M O'Sullivan
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

2.  Research perspectives: gold nanoparticles in cancer theranostics.

Authors:  Junjie Li; Sanjay Gupta; Chun Li
Journal:  Quant Imaging Med Surg       Date:  2013-12

3.  DNA damage enhancement from gold nanoparticles for clinical MV photon beams.

Authors:  Ross I Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D Price; Alec Kimmelman; G Mike Makrigiorgos
Journal:  Radiat Res       Date:  2012-11-13       Impact factor: 2.841

Review 4.  Radiosensitization by gold nanoparticles.

Authors:  B Jeremic; A R Aguerri; N Filipovic
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

Review 5.  Radiosensitizing properties of magnetic hyperthermia mediated by superparamagnetic iron oxide nanoparticles (SPIONs) on human cutaneous melanoma cell lines.

Authors:  Jakub Dalibor Rybka
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-06

Review 6.  Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy.

Authors:  Sunil Krishnan; Parmeswaran Diagaradjane; Sang Hyun Cho
Journal:  Int J Hyperthermia       Date:  2010-09-21       Impact factor: 3.914

Review 7.  Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Authors:  Jihyoun Lee; Dev Kumar Chatterjee; Min Hyuk Lee; Sunil Krishnan
Journal:  Cancer Lett       Date:  2014-02-17       Impact factor: 8.679

8.  The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources.

Authors:  Sang Hyun Cho; Bernard L Jones; Sunil Krishnan
Journal:  Phys Med Biol       Date:  2009-07-27       Impact factor: 3.609

Review 9.  Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

Authors:  Wilfred Ngwa; Rajiv Kumar; Srinivas Sridhar; Houari Korideck; Piotr Zygmanski; Robert A Cormack; Ross Berbeco; G Mike Makrigiorgos
Journal:  Nanomedicine (Lond)       Date:  2014-05       Impact factor: 5.307

10.  Radiosensitization Effects by Bismuth Oxide Nanoparticles in Combination with Cisplatin for High Dose Rate Brachytherapy.

Authors:  Noor Nabilah Talik Sisin; Khairunisak Abdul Razak; Safri Zainal Abidin; Nor Fazila Che Mat; Reduan Abdullah; Raizulnasuha Ab Rashid; Muhammad Afiq Khairil Anuar; Nur Hamizah Mohd Zainudin; Nashrulhaq Tagiling; Norazlina Mat Nawi; Wan Nordiana Rahman
Journal:  Int J Nanomedicine       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.